Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 183

    1.

    Suspension of anticytomegalovirus maintenance therapy following immune recovery due to highly active antiretroviral therapy.

    Curi AL, Muralha A, Muralha L, Pavesio C.

    Br J Ophthalmol. 2001 Apr;85(4):471-3.PMID: 11264139 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.

    Whitcup SM, Fortin E, Lindblad AS, Griffiths P, Metcalf JA, Robinson MR, Manischewitz J, Baird B, Perry C, Kidd IM, Vrabec T, Davey RT Jr, Falloon J, Walker RE, Kovacs JA, Lane HC, Nussenblatt RB, Smith J, Masur H, Polis MA.

    JAMA. 1999 Nov 3;282(17):1633-7.PMID: 10553789 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.
    4.

    Discontinuing anticytomegalovirus therapy in patients with immune reconstitution after combination antiretroviral therapy.

    Jabs DA, Bolton SG, Dunn JP, Palestine AG.

    Am J Ophthalmol. 1998 Dec;126(6):817-22.PMID: 9860006 [PubMed - indexed for MEDLINE]Related articles

    5.

    Discontinuation of maintenance therapy for cytomegalovirus retinitis in HIV-infected patients receiving highly active antiretroviral therapy.

    Jouan M, Savès M, Tubiana R, Carcelain G, Cassoux N, Aubron-Olivier C, Fillet AM, Nciri M, Sénéchal B, Chêne G, Tural C, Lasry S, Autran B, Katlama C; RESTIMOP study team.

    AIDS. 2001 Jan 5;15(1):23-31.PMID: 11192865 [PubMed - indexed for MEDLINE]Related articles

    6.

    Withdrawal of maintenance therapy for cytomegalovirus retinitis in AIDS patients exhibiting immunological response to HAART.

    Waib LF, Bonon SH, Salles AC, Benard G, de Oliveira AC, Pannuti CS, Pedro Rde J, Costa SC.

    Rev Inst Med Trop Sao Paulo. 2007 Jul-Aug;49(4):215-9.PMID: 17823749 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Highly active antiretroviral therapy-related immune recovery in AIDS patients with cytomegalovirus retinitis.

    Macdonald JC, Karavellas MP, Torriani FJ, Morse LS, Smith IL, Reed JB, Freeman WR.

    Ophthalmology. 2000 May;107(5):877-81; discussion 881-3.PMID: 10811078 [PubMed - indexed for MEDLINE]Related articles

    8.

    Long-term follow-up of a cohort of HIV-infected patients who discontinued maintenance therapy for cytomegalovirus retinitis.

    Walmsley SL, Raboud J, Angel JB, Mazzulli T, Shen S, Casciaro L, Young CD, Moussa G, Gough K, Rachlis A, Hopkins J.

    HIV Clin Trials. 2006 Jan-Feb;7(1):1-9.PMID: 16632459 [PubMed - indexed for MEDLINE]Related articles

    9.

    Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy in HIV infected patients: natural history and clinical predictors.

    Lin DY, Warren JF, Lazzeroni LC, Wolitz RA, Mansour SE.

    Retina. 2002 Jun;22(3):268-77.PMID: 12055458 [PubMed - indexed for MEDLINE]Related articles

    10.

    Characterization of reactivation of cytomegalovirus retinitis in patients healed after treatment with highly active antiretroviral therapy.

    Song MK, Karavellas MP, MacDonald JC, Plummer DJ, Freeman WR.

    Retina. 2000;20(2):151-5.PMID: 10783947 [PubMed - indexed for MEDLINE]Related articles

    11.

    Discontinuation of maintenance therapy in patients with quiescent cytomegalovirus retinitis and elevated CD4+ counts.

    Vrabec TR, Baldassano VF, Whitcup SM.

    Ophthalmology. 1998 Jul;105(7):1259-64.PMID: 9663231 [PubMed - indexed for MEDLINE]Related articles

    12.

    Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy.

    Macdonald JC, Torriani FJ, Morse LS, Karavellas MP, Reed JB, Freeman WR.

    J Infect Dis. 1998 May;177(5):1182-7.PMID: 9593001 [PubMed - indexed for MEDLINE]Related articles

    13.

    Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 1. Retinitis progression.

    Jabs DA, Van Natta ML, Thorne JE, Weinberg DV, Meredith TA, Kuppermann BD, Sepkowitz K, Li HK; Studies of Ocular Complications of AIDS Research Group.

    Ophthalmology. 2004 Dec;111(12):2224-31.PMID: 15582078 [PubMed - indexed for MEDLINE]Related articles

    14.

    Effect of anti-cytomegalovirus therapy on the incidence of immune recovery uveitis in AIDS patients with healed cytomegalovirus retinitis.

    Song MK, Azen SP, Buley A, Torriani F, Cheng L, Chaidhawangul S, Ozerdem U, Scholz B, Freeman WR.

    Am J Ophthalmol. 2003 Oct;136(4):696-702.PMID: 14516810 [PubMed - indexed for MEDLINE]Related articles

    15.

    Discontinuing anticytomegalovirus therapy in patients with cytomegalovirus retinitis and AIDS.

    Jabs DA.

    Br J Ophthalmol. 2001 Apr;85(4):381-2. No abstract available. PMID: 11264121 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Cystoid macular oedema and cytomegalovirus retinitis in patients with HIV disease treated with highly active antiretroviral therapy.

    Cassoux N, Lumbroso L, Bodaghi B, Zazoun L, Katlama C, LeHoang P.

    Br J Ophthalmol. 1999 Jan;83(1):47-9.PMID: 10209434 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Cytomegalovirus retinitis in the era of highly active antiretroviral therapy.

    Whitcup SM.

    JAMA. 2000 Feb 2;283(5):653-7.PMID: 10665706 [PubMed - indexed for MEDLINE]Related articles

    18.

    Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).

    Holland GN, Vaudaux JD, Shiramizu KM, Yu F, Goldenberg DT, Gupta A, Carlson M, Read RW, Novack RD, Kuppermann BD; Southern California HIV/Eye Consortium.

    Am J Ophthalmol. 2008 Jan;145(1):12-22.PMID: 18154751 [PubMed - indexed for MEDLINE]Related articles

    19.

    The safety of discontinuation of maintenance therapy for cytomegalovirus (CMV) retinitis and incidence of immune recovery uveitis following potent antiretroviral therapy.

    Wohl DA, Kendall MA, Owens S, Holland G, Nokta M, Spector SA, Schrier R, Fiscus S, Davis M, Jacobson MA, Currier JS, Squires K, Alston-Smith B, Andersen J, Freeman WR, Higgins M, Torriani FJ; ACTG 379 Study Team.

    HIV Clin Trials. 2005 May-Jun;6(3):136-46.PMID: 16192248 [PubMed - indexed for MEDLINE]Related articles

    20.

    Influence of highly active antiretroviral therapy on the development of CMV disease in HIV positive patients at high risk for CMV disease.

    Verbraak FD, Boom R, Wertheim-van Dillen PM, van den Horn GJ, Kijlstra A, de Smet MD.

    Br J Ophthalmol. 1999 Oct;83(10):1186-9.PMID: 10502584 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data